PMID- 28708905 OWN - Quintessenz Verlags-GmbH CI - Copyright Quintessenz Verlags-GmbH OCI - Copyright Quintessenz Verlags-GmbH TA - Int J Oral Maxillofac Implants JT - The International Journal of Oral & Maxillofacial Implants IS - 1942-4434 (Electronic) IS - 0882-2786 (Print) IP - 4 VI - 32 PST - ppublish DP - 2017 PG - 717-734 LA - en TI - Clinical Performance of Dental Implants with a Moderately Rough (TiUnite) Surface: A Meta-Analysis of Prospective Clinical Studies LID - 10.11607/jomi.5699 [doi] FAU - Karl, Matthias AU - Karl M FAU - Albrektsson, Tomas AU - Albrektsson T CN - OT - implant surface OT - implant survival rate OT - marginal bone level change OT - meta-analysis OT - moderately rough OT - prospective clinical study AB - Purpose: A moderately rough anodized titanium implant surface (TiUnite) was introduced in 2000. This review and meta-analysis aimed to assess implant survival and marginal bone level (MBL) changes documented in the literature. Materials and Methods: Repeated literature searches on dental implants were conducted, with the final search on October 7, 2016. The inclusion criteria were: prospective study, minimum of 20 patients, at least 12 months follow-up postloading, and TiUnite implant survival reported. Regression analysis was performed on implant survival and MBL change from implant surgery. Peri-implantitis as defined by the primary authors was reported at the patient level. Results: One hundred six out of 32,519 publications on dental implants met the inclusion criteria. Implant survival rates at 1 year were 99.50% at the implant level and 99.12% at the patient level, and survival rates at 10 years were 95.14% at the implant level and 91.50% at the patient level. Mean MBL change at 1 year was -0.409 mm at the implant level and -0.413 mm at the patient level, and at 5 years, it was -0.886 mm at the implant level and -1.029 mm at the patient level. Nineteen studies (18%) specifically reported peri-implantitis in 64 out of 1,229 patients with a mean followup of 47.89 months, indicating a prevalence of 5.20% at the patient level. Conclusion: Based on a metaanalysis of prospective studies, implants with the TiUnite surface provide a predictable treatment modality in a variety of indications. AID - 846984